AXIKIN PHARMACEUTICALS INC — Form D/A
AXIKIN PHARMACEUTICALS INC of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2015-09-28. The offering totals $11.6M, of which $6.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-09-28
- Form: D/A
- Accession: 0001439059-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.6M
- Amount sold: $6.5M
- Remaining: $5.1M
- Investors: 7
- Date of first sale: 2014-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-214321
Issuer
- Name: AXIKIN PHARMACEUTICALS INC
- CIK: 0001439059
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 10835 Road To The Cure, SAN DIEGO, CA, 92121
- Phone: 858-458-1890
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Kevin B Bacon | Director | San Diego, CA |
| Masaji CM Matsuoka | Director | Menlo Park, CA |
| Peter CM McWilliams | Director | San Francisco, CA |
| Fred A Middleton | Director | Chapel Hill, NC |
| Kevin B Bacon | Executive Officer | San Diego, CA |
| Peter CM McWilliams | Executive Officer | San Francisco, CA |
| Dan CM Liu | Director | Menlo Park, CA |
| Walter CM Olesiak | Director | New York, NY |
Other filings by this issuer (3)
More